
September 25, 2023
Washington DC’s VerImmune Announces Over $3M Additional Funding
WASHINGTON, Sept. 20, 2023 /PRNewswire/ -- VerImmune Inc. ("VerImmune"), an early-stage biotechnology company specializing in the development of innovative products…